|
2009 Conference Publication Angiomotin-like protein 2 (AmotL2), a potential target for cancer therapyWolfram, Joy, Mojallal, M., Zheng, Y. and Holmgren, L. (2009). Angiomotin-like protein 2 (AmotL2), a potential target for cancer therapy. Amgen Scholars Symposium, Cambridge, United Kingdom, September 2009. |
